Assistant Professor, Clinical Medicine

Christopher HanksMedical Director, The Center for Autism Services and Transition 


The Ohio State University Wexner Medical Center
Department of internal Medicine 
General Internal Medicine and Pediatrics at Hilliard 
3691 Ridge Mill Drive
Hilliard, OH 43026

Christopher.Hanks@osumc.edu

614-688-9220


In Internal Medicine and Pediatrics at Hilliard, Dr. Chris Hanks works primarily with patients diagnosed with chronic childhood illness, with a specific focus on autism. Dr. Hanks works with young adults and adults and he focuses on improving access to care by understanding potential barriers and helping patients navigate the healthcare system.

Dr. Hanks is involved in programs designed to develop new approaches of treatment for autism, which will then be expanded to medical professionals throughout The Ohio State University. 

Currently, he is involved in a review-based research project, which is being carried out using existing teenage patients. By obtaining details on these patients’ experiences, gaps in the healthcare system can be modified as they transition into adult care.


Education and Training


Chief Medical Resident: Internal Medicine, The Ohio State University 

MD: Penn State University College of Medicine                      
                     
                                                                    
Professional Awards

James N. Allen Housestaff Award for Excellence in Pulmonary Medicine: The Ohio State University Internal Medicine Residency

Resident Teaching Award: Department of Pediatrics, The Ohio State University College of Medicine

Mentor of the Year, 2011: Department of Internal Medicine Student Education Programs, The Ohio State University

Resident Teaching Excellence Award: Department of Internal Medicine Student Education Programs, The Ohio State University 


Abstracts and Peer-Reviewed Journal Articles

Bates K., Nourie C.E., Hanks C., and Friedland, A.  “Legal Options, Challenges and Insights in Supporting Young Adults with Disabilities.” SGIM Forum 2013; 36(4): 6, 13. 

Hanks CD., Parsons JP., Benninger C., Kaeding C., Best T., Phillips G., Mastronarde JG. “Etiology of Dyspnea in Elite and Recreational Athletes.”  The Physician and Sportsmedicine 2012 May; 2: 28-33. 
 
Thapliyal A., Bannister R., Hanks C., Adams B.  “The monomeric G proteins AGS1 and Rhes selectively influence Gαi-dependent signaling to modulate N-type (CaV2.2) calcium channels.”  Am J Physiol Cell Physiol 2008 Sept; 295: C1417-C1426. 
 
Santos C.B., Hanks C., McCann J., Lehman E.B., Pratt E., Craig T.J.  “The role of montelukast on perennial allergic rhinitis and associated sleep disturbances and daytime somnolence.”  Allergy and Asthma Proceedings 2008 Mar; 29(2): 140-145. 

Santos C.B., Pratt E.L., Hanks C., McCann J., Craig T.J.  “Allergic rhinitis and its effects on sleep, fatigue, and daytime somnolence.”  Ann Allergy Asthma Immunol 2006 Nov; 97(5): 579-86.

Gibbs J., Hanks C., McCann J., et al.  ”Allergic rhinitis and sleep disturbances.”   Otorinolaringol. 2006; 56: 27-35.  

Craig T.J., Hanks C.D., and Fisher L.H. “How do topical nasal corticosteroids improve sleep and daytime somnolence in allergic rhinitis?”  J Allergy Clin Immunol 2005; 116(6):1264-6.